Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXN6T1
|
||||
| Drug Name |
(S)-N-(1-(cyanomethylamino)-1-oxo-3-(3-(pyridin-2-yl)phenyl)propan-2-yl)benzamide
|
||||
| Synonyms |
CHEMBL556434
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H20N4O2
|
||||
| Canonical SMILES |
O=C(NCC#N)[C@H](Cc1cccc(c1)c2ccccn2)NC(=O)c3ccccc3
|
||||
| InChI |
InChI=1S/C23H20N4O2/c24-12-14-26-23(29)21(27-22(28)18-8-2-1-3-9-18)16-17-7-6-10-19(15-17)20-11-4-5-13-25-20/h1-11,13,15,21H,14,16H2,(H,26,29)(H,27,28)/t21-/m0/s1
|
||||
| InChIKey |
XWMHXUUSBYGQDC-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.